What is Glooko?
Glooko operates at the intersection of healthcare technology and patient-centric digital therapeutics. The company provides a sophisticated, intelligent, and connected care platform designed to improve health outcomes for individuals living with chronic conditions. By revolutionizing the interaction between patients and healthcare providers, Glooko facilitates seamless data integration, which is essential for driving patient engagement and optimizing treatment adherence. Furthermore, the platform serves as a critical infrastructure for accelerating clinical trials, positioning Glooko as an indispensable partner for pharmaceutical companies and healthcare institutions seeking to leverage real-world evidence to improve therapeutic efficacy and operational efficiency in the digital health sector.
How much funding has Glooko raised?
Glooko has raised a total of $190.5M across 7 funding rounds:
Angel/Seed
$1M
Series A
$7M
Series B
$16.5M
Series C
$35M
Debt
$1M
Series D
$30M
Series F
$100M
Angel/Seed (2011): $1M with participation from Bill Campbell, Annad Rajarman, Judy Estrin, Social+Capital, Russel Hirsch, Andy Hertzfeld, Xtreme Labs, Venky Harinarayan, Vint Cerf, and Anand Agarawala
Series A (2014): $7M led by The Social+Capital Partnership and Samsung Ventures
Series B (2015): $16.5M supported by Medtronic, Canaan Capital, Samsung Ventures, and The Social + Capital Partnership
Series C (2017): $35M featuring Canaan Partners, Georgian, Mayo Clinic, Insulet, Samsung NEXT, and Medtronic
Debt (2020): $1M backed by PPP
Series D (2021): $30M with participation from Health Catalyst Capital Management, Georgian, Insulet, Canaan Partners, Mayo Clinic, and Novo Nordisk
Series F (2024): $100M led by Georgian and Health Catalyst Capital Management
Key Investors in Glooko
Canaan Partners
Canaan is an early-stage venture capital firm that invests in technology and healthcare companies, backing founders from seed through growth stages in areas such as enterprise software, fintech, consumer, biopharma, and digital health.
Mayo Clinic
Mayo Clinic is a nonprofit global healthcare organization specializing in integrated clinical practice, education, and medical research, bringing together specialists to address complex health conditions.
Medtronic
Medtronic is a global healthcare technology company that develops and manufactures medical devices, therapies, and digital health solutions to improve patient outcomes across cardiovascular and diabetes technologies.
What's next for Glooko?
With the successful closure of this latest funding round, Glooko is well-positioned to scale its operations and expand its footprint in the competitive digital health market. The strategic focus will likely center on deepening its integration with existing clinical workflows and expanding its suite of digital therapeutics to address a broader spectrum of chronic diseases. As the healthcare industry shifts toward value-based care models, Glooko's data-driven approach provides a scalable framework for reducing costs while simultaneously improving patient quality of life. Future initiatives will likely involve enhancing the platform's AI-driven analytics capabilities to provide more personalized, actionable insights for both patients and clinicians, thereby cementing its status as a cornerstone of the future of connected health.
See full Glooko company page
